CHRNA4 and Parkinsonism: Treatment options for neurological diseases, including Parkinson’s, Alzheimer’s, schizophrenia, and nicotine addiction, are limited by insufficient understanding of nAChR-mediated cell signaling in response to ligand binding [6,7].